<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) September 26, 2000
-------------------------------
CELL THERAPEUTICS, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in charter)
Washington 0-28386 91-1533912
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
201 Elliott Avenue West, Suite 400, Seattle, WA 98119
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (206) 278-7100
--------------------------------------------------------------------------------
NOT APPLICABLE
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
<PAGE>
Item 5. Other Events
Cell Therapeutics, Inc. received approval for TRISENOX (arsenic trioxide)
injection by the U.S. Food and Drug Administration on September 26, 2000 for the
treatment of patients with acute promyelocytic leukemia, a severe form of
leukemia, whose disease has recurred or who have failed to respond to standard
therapy.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
The following exhibit is filed as part of this Report:
99.1 Press Release dated September 26, 2000.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
CELL THERAPEUTICS, INC.
Date: September 26, 2000 /s/ JAMES A. BIANCO
---------------------------------
Name: James A. Bianco
Title: Chief Executive Officer
-3-
<PAGE>
EXHIBIT INDEX
99.1 Press Release dated September 26, 2000.
-4-
